Prashant Desai
About Prashant Desai
Prashant Desai is the Head of Medical Affairs with a 23-year career in clinical research, specializing in various aspects of operations, project management, and medical affairs.
Prashant Desai - Head of Medical Affairs
Prashant Desai serves as the Head of Medical Affairs, leveraging his extensive experience and training as a physician. In his role, he oversees medical strategies, ensuring alignment with patient care priorities. Desai's responsibilities encompass a wide range of clinical settings, contributing to the advancement of medical research and patient outcomes.
Prashant Desai's 23-Year Career in Clinical Research
Prashant Desai has dedicated 23 years to the field of clinical research. His career spans various domains including operations, project management, site management, business development, and medical affairs. His extensive background underscores his expertise in executing and managing clinical trials, ensuring high standards of research and patient care.
Prashant Desai's Work at Leading CROs
Throughout his career, Prashant Desai has contributed his expertise to prominent Clinical Research Organizations (CROs) such as Quintiles, Parexel, Premier Research, and Ergomed. His roles in these organizations have involved developing and managing clinical trials, with a particular focus on cardiovascular safety and expanding into diverse therapy areas.
Experience in Global Clinical Trials and End Point Data Collection
Prashant Desai has been integral in the start-up and setup of global clinical trials across various indications and therapy areas. His work at organizations like Clario (previously ERT) and Calyx involved critical end point data collection, contributing to the reliability and validity of clinical research outcomes.
Prashant Desai's Focus on Patient Care
Prashant Desai is known for his dedicated focus on patient care throughout his career in clinical research. As a passionate team player, he emphasizes collaboration and patient-centric strategies in all aspects of his work. His approach ensures that clinical trials not only meet scientific and operational benchmarks but also prioritize the well-being of patients.